Antiatherogenic properties of high-density lipoprotein-enriched microRNAs
- PMID: 24764456
- PMCID: PMC4288964
- DOI: 10.1161/ATVBAHA.114.303542
Antiatherogenic properties of high-density lipoprotein-enriched microRNAs
Keywords: HDL; commentary; endothelium; microRNA; post-transcriptional gene silencing.
Comment on
-
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells.Nat Commun. 2014 Feb 28;5:3292. doi: 10.1038/ncomms4292. Nat Commun. 2014. PMID: 24576947 Free PMC article.
References
-
- Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell. 2001;104:503–16. - PubMed
-
- Rosenson RS, Brewer HB, Jr, Davidson WS, Fayad ZA, Fuster V, Goldstein J, Hellerstein M, Jiang XC, Phillips MC, Rader DJ, Remaley AT, Rothblat GH, Tall AR, Yvan-Charvet L. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation. 2012;125:1905–19. - PMC - PubMed
-
- Rader DJ, Tall AR. The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis? Nature medicine. 2012;18:1344–6. - PubMed
-
- Toth PP, Barter PJ, Rosenson RS, Boden WE, Chapman MJ, Cuchel M, D’Agostino RB, Sr, Davidson MH, Davidson WS, Heinecke JW, Karas RH, Kontush A, Krauss RM, Miller M, Rader DJ. High-density lipoproteins: a consensus statement from the National Lipid Association. Journal of clinical lipidology. 2013;7:484–525. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
